Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment

By NS Medical Staff Writer

06 Apr 23

Celanese to Supply VitalDose Drug Delivery Platform for Glaukos’ Investigational iDose TR Intraocular Implant

DevicesOphthalmic

Perfuse Therapeutics Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of PER-001 Intravitreal Implant in Patients with Glaucoma

By NS Medical Staff Writer

05 Apr 23

This milestone marks transition of Perfuse Therapeutics to a clinical-stage company

DevicesOphthalmic

Pixium’s Prima System gets FDA breakthrough designation in dry AMD

By NS Medical Staff Writer

03 Apr 23

The Prima System is designed as a photovoltaic substitute for photoreceptors that offers simultaneous use of the central…

DevicesOphthalmic

ISTAR implants first patients in STAR-VI trial of MINIject MIGS device

By NS Medical Staff Writer

16 Mar 23

MINIject is said to be a minimally-invasive glaucoma surgery device that is currently the only commercially available MIGS…

DevicesOphthalmic

Ben Wilson, MD, at Woolfson Eye First in Asheville to Offer Light Adjustable Lens Implant

By NS Medical Staff Writer

13 Mar 23

The state-of-the-art technology is the only intraocular lens implant that enables eye care providers to non-surgically customize a…

DevicesOphthalmic

Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System

By NS Medical Staff Writer

10 Mar 23

The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma…

DevicesOphthalmic

AffaMed Technologies Announces the First Implantation in the China Registrational Clinical Trial of MINI WELL

By NS Medical Staff Writer

06 Mar 23

MINI WELL® EDOF IOL is an innovative IOL implant for the Greater China market, offering a great alternative…

DevicesOphthalmic

ViaLase FLigHT treatment yields positive results in first-in-human study

By NS Medical Staff Writer

03 Mar 23

The results demonstrated ViaLase FLigHT's potential as a safe and effective treatment option for primary open angle glaucoma

DevicesOphthalmic

CooperVision’s Latest Innovation, MyDay Energys Contact Lenses, Make U.S. Debut

By NS Medical Staff Writer

02 Mar 23

UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they…

DevicesOphthalmic

Celanese, Johns Hopkins to study sustained ocular drug delivery to suprachoroidal space

By NS Medical Staff Writer

16 Feb 23

The findings from the study can offer useful insights to support the treatment paradigm for retinal disorders with…

DevicesOphthalmic